Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Preparation, characterization, and cytotoxicity of CPT/Fe2O3-embedded PLGA ultrafine composite fibers: a synergistic approach to develop promising anticancer material
Authors Amna T, Hassan MS, Nam KT, Bing YY, Barakat NAM , Khil MS, Kim HY
Received 26 December 2011
Accepted for publication 11 February 2012
Published 27 March 2012 Volume 2012:7 Pages 1659—1670
DOI https://doi.org/10.2147/IJN.S24467
Review by Single-blind
Peer reviewer comments 2
Video abstract presented by Touseef Amna
Views: 538
Touseef Amna1, M Shamshi Hassan2, Ki-Taek Nam2, Yang You Bing3, Nasser AM Barakat2, Myung-Seob Khil2, Hak Yong Kim1,2
1Center for Healthcare Technology Development, 2Department of Organic Materials and Fiber Engineering, Chonbuk National University, Jeonju, Korea; 3Animal Science and Technology College, Henan University of Science and Technology, Luoyang, China
Abstract: The aim of this study was to fabricate camptothecin/iron(III) oxide (CPT/Fe2O3)-loaded poly(D,L-lactide-co-glycolide) (PLGA) composite mats to modulate the CPT release and to improve the structural integrity and antitumor activity of the released drug. The CPT/ Fe2O3-loaded PLGA ultrafine fibers were prepared for the first time by electrospinning a composite solution of CPT/Fe2O3 and neat PLGA (4 weight percent). The physicochemical characterization of the electrospun composite mat was carried out by scanning electron microscopy, energy dispersive X-ray spectroscopy, electron probe microanalysis, thermogravimetry, transmission electron microscopy, ultraviolet-visible spectroscopy, and X-ray diffraction pattern. The medicated composite fibers were evaluated for their cytotoxicity on C2C12 cells using Cell Counting Kit-8 assay (Sigma-Aldrich Corporation, St Louis, MO). The in vitro studies indicated a slow and prolonged release over a period of 96 hours with mild initial burst. Scanning electron microscopy, thermogravimetry, and X-ray diffraction studies confirmed the interaction of CPT/Fe2O3 with the PLGA matrix and showed that the crystallinity of CPT decreased after loading. Incorporation of CPT in the polymer media affected both the morphology and the size of the CPT/Fe2O3-loaded PLGA composite fibers. Electron probe microanalysis and energy dispersive X-ray spectroscopy results confirmed well-oriented composite ultrafine fibers with good incorporation of CPT/Fe2O3. The cytotoxicity results illustrate that the pristine PLGA did not exhibit noteworthy cytotoxicity; conversely, the CPT/Fe2O3 composite fibers inhibited C2C12 cells significantly. Thus, the current work demonstrates that the CPT/Fe2O3-loaded PLGA composite fibers represent a promising chemotherapeutic system for enhancing anticancer drug efficacy and selectively targeting cancer cells in order to treat diverse cancers.
Keywords: camptothecin, C2C12 cells, Fe2O3 nanoparticles, electrospinning, cytotoxicity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other article by this author:
Virgin olive oil blended polyurethane micro/nanofibers ornamented with copper oxide nanocrystals for biomedical applications
Amna T, Hassan MS, Yang J, Khil MS, Song KD, Oh JD, Hwang I
International Journal of Nanomedicine 2014, 9:891-898
Published Date: 13 February 2014
Readers of this article also read:
Nanopharmacology in translational hematology and oncology
Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I
International Journal of Nanomedicine 2014, 9:3465-3479
Published Date: 22 July 2014
Characterization, activity, and computer modeling of a molecular inclusion complex containing rifaldazine
Tan Q, He D, Wu M, Yang L, Ren Y, Liu J, Zhang J
International Journal of Nanomedicine 2013, 8:477-484
Published Date: 1 February 2013
The potential benefit of stem cell therapy after stroke: an update
Banerjee S, Williamson DA, Habib N, Chataway J
Vascular Health and Risk Management 2012, 8:569-580
Published Date: 10 October 2012
Acoustic cardiac signals analysis: a Kalman filter–based approach
Salleh SH, Hussain HS, Swee TT, Ting CM, Noor AM, Pipatsart S, Ali J, Yupapin PP
International Journal of Nanomedicine 2012, 7:2873-2881
Published Date: 11 June 2012
Study of the intra-arterial distribution of Fe3O4 nanoparticles in a model of colorectal neoplasm induced in rat liver by MRI and spectrometry
Echevarria-Uraga JJ, García-Alonso I, Plazaola F, Insausti M, Etxebarria N, Saiz-López A, Fernández-Ruanova B
International Journal of Nanomedicine 2012, 7:2399-2410
Published Date: 9 May 2012
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
Hanagata N
International Journal of Nanomedicine 2012, 7:2181-2195
Published Date: 27 April 2012
Association between calcifying nanoparticles and placental calcification
Guo Y, Zhang D, Lu H, Luo S, Shen X
International Journal of Nanomedicine 2012, 7:1679-1686
Published Date: 27 March 2012
Erratum
Iancu C, Mocan L
International Journal of Nanomedicine 2011, 6:2543-2544
Published Date: 21 October 2011
Nanotoxicology and nanoparticle safety in biomedical designs
Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, Zafari M, Akbari HR, Rad HG
International Journal of Nanomedicine 2011, 6:1117-1127
Published Date: 31 May 2011
Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity
Kamyar Shameli, Mansor Bin Ahmad, Mohsen Zargar, et al
International Journal of Nanomedicine 2011, 6:271-284
Published Date: 27 January 2011
